Company Search:
Advanced Search
Sponsored Links
Genovate Biotechnology Co., Limited Company Snapshot
Genovate Biotechnology Co., Limited operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Genovate Biotechnology Co., Limited with three other companies in this sector in TAIWAN : Sagittarius Life Science Corp. (2019 sales of 438.72 million Taiwanese Dollars [US$14.95 million] ), Tien Liang Biotech Co Ltd (435.86 million Taiwanese Dollars [US$14.85 million] ), and UBI Pharma Inc (479.56 million Taiwanese Dollars [US$16.34 million] of which 80% was Contract Medicine Manufacturing).

Sales Analysis. During the year ended December of 2019, sales at Genovate Biotechnology Co., Limited were 465.76 million Taiwanese Dollars (US$15.87 million). This is an increase of 2.2% versus 2018, when the company's sales were 455.80 million Taiwanese Dollars . The sales level in 2019 was fairly close to the level five years ago: in 2014, Genovate Biotechnology Co., Limited had sales of 475.45 million Taiwanese Dollars . Sales of Agency saw an increase that was more than double the company's growth rate: sales were up 51.1% in 2019, from 15.19 million Taiwanese Dollars to 22.94 million Taiwanese Dollars . Not all segments of Genovate Biotechnology Co., Limited experienced an increase in sales in 2019: sales of Other fell 84.6% to 278,000.00 Taiwanese Dollars . (However, this segment's sales were only a very small portion of the company's overall sales). Genovate Biotechnology Co., Limited also experienced decreases in sales in Technical Service (down 67.5% to 3.91 million Taiwanese Dollars ) .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Genovate Biotechnology Co., Limited
  Stock Performance Chart for Genovate Biotechnology Co., Limited
  Stock Data: Recent Stock Performance:
  Current Price (7/31/2020): 40.05
(Figures in Taiwanese Dollars )
1 Week -1.5%   13 Weeks 13.3%  
4 Weeks 44.6%   52 Weeks 49.7%  
Genovate Biotechnology Co., Limited Key Data:
  Ticker: 4130 Country: Taiwan
  Exchanges: TAI Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2019 Sales 465,756,000
(Year Ending Jan 2020).
Employees: 178
  Currency: Taiwanese Dollars Market Cap: 4,152,664,350
  Fiscal Yr Ends: December Shares Outstanding: 103,687,000
  Share Type: Gu Closely Held Shares: 41,313,000
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.